Works matching IS 01418955 AND DT 2024 AND VI 47 AND IP 3
Results: 14
The continuously evolving phenotype of succinic semialdehyde dehydrogenase deficiency.
- Published in:
- Journal of Inherited Metabolic Disease, 2024, v. 47, n. 3, p. 447, doi. 10.1002/jimd.12723
- By:
- Publication type:
- Article
Neurotransmitters ... it is all about communication!
- Published in:
- Journal of Inherited Metabolic Disease, 2024, v. 47, n. 3, p. 409, doi. 10.1002/jimd.12748
- By:
- Publication type:
- Article
Gene replacement therapies for inherited disorders of neurotransmission: Current progress in succinic semialdehyde dehydrogenase deficiency.
- Published in:
- Journal of Inherited Metabolic Disease, 2024, v. 47, n. 3, p. 476, doi. 10.1002/jimd.12735
- By:
- Publication type:
- Article
Mouse models for inherited monoamine neurotransmitter disorders.
- Published in:
- Journal of Inherited Metabolic Disease, 2024, v. 47, n. 3, p. 533, doi. 10.1002/jimd.12710
- By:
- Publication type:
- Article
Tetrahydrobiopterin (BH<sub>4</sub>) treatment stabilizes tyrosine hydroxylase: Rescue of tyrosine hydroxylase deficiency phenotypes in human neurons and in a knock‐in mouse model.
- Published in:
- Journal of Inherited Metabolic Disease, 2024, v. 47, n. 3, p. 494, doi. 10.1002/jimd.12702
- By:
- Publication type:
- Article
Tyrosine hydroxylase variants influence protein expression, cellular localization, stability, enzymatic activity and the physical interaction between tyrosine hydroxylase and GTP cyclohydrolase 1.
- Published in:
- Journal of Inherited Metabolic Disease, 2024, v. 47, n. 3, p. 517, doi. 10.1002/jimd.12690
- By:
- Publication type:
- Article
Metabolic characterization of neurogenetic disorders involving glutamatergic neurotransmission.
- Published in:
- Journal of Inherited Metabolic Disease, 2024, v. 47, n. 3, p. 551, doi. 10.1002/jimd.12689
- By:
- Publication type:
- Article
Navigating the rare neurotransmitter disease diagnosis: Insights from patients and health care professionals.
- Published in:
- Journal of Inherited Metabolic Disease, 2024, v. 47, n. 3, p. 413, doi. 10.1002/jimd.12675
- By:
- Publication type:
- Article
Development of precision therapies for rare inborn errors of metabolism: Functional investigations in cell culture models.
- Published in:
- Journal of Inherited Metabolic Disease, 2024, v. 47, n. 3, p. 509, doi. 10.1002/jimd.12674
- By:
- Publication type:
- Article
Levodopa‐refractory hyperprolactinemia and pituitary findings in inherited disorders of biogenic amine metabolism.
- Published in:
- Journal of Inherited Metabolic Disease, 2024, v. 47, n. 3, p. 431, doi. 10.1002/jimd.12658
- By:
- Publication type:
- Article
Patient‐initiated conference focuses on bridging gaps between patients, clinicians and scientists in the field of rare neurotransmitter‐related disorders.
- Published in:
- Journal of Inherited Metabolic Disease, 2024, v. 47, n. 3, p. 411, doi. 10.1002/jimd.12641
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Journal of Inherited Metabolic Disease, 2024, v. 47, n. 3, p. 1, doi. 10.1002/jimd.12629
- Publication type:
- Article
Succinic semialdehyde dehydrogenase deficiency in mice and in humans: An untargeted metabolomics perspective.
- Published in:
- Journal of Inherited Metabolic Disease, 2024, v. 47, n. 3, p. 417, doi. 10.1002/jimd.12657
- By:
- Publication type:
- Article
Gene therapy for aromatic L‐amino acid decarboxylase deficiency: Requirements for safe application and knowledge‐generating follow‐up.
- Published in:
- Journal of Inherited Metabolic Disease, 2024, v. 47, n. 3, p. 463, doi. 10.1002/jimd.12649
- By:
- Publication type:
- Article